Author:
Müller Svenja,Lieb Klaus,Streit Fabian,Awasthi Swapnil,Wagner Stefanie,Frank Josef,Müller Marianne B.,Tadic André,Heilmann-Heimbach Stefanie,Hoffmann Per,Mavarani Laven,Schmidt Börge,Rietschel Marcella,Witt Stephanie H.,Zillich Lea,Engelmann Jan
Reference51 articles.
1. MINI Plus: MINI International Neuropsychiatric Interview, Deutsche Version 5.0. 0;Ackenheil,1998
2. Practice Guideline for the Treatment of Patients With Major Depressive Disorder;American Psychiatric Association (APA),2010
3. Polygenic scores for psychiatric disease: from research tool to clinical application;Andlauer;Med. Genet.,2020
4. Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study;Biernacka;Neuropsychopharmacology,2021
5. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants;Bousman;Clin. Pharmacol. Ther.,2023